Several hotspots and thinking in the use of non-selective β-blockers in Chinese cirrhosis patients

doi:10.3877/cma.j.issn.2095-2015.2020.05.001

Abstract

Abstract:

Non-selective β-blockers are the first-line treatment for portal hypertension through dual effect of decreasing portal venous pressure and improving hemodynamic dysfunction. However, Chinese patients may not benefit from the therapy due to low awareness and inadequate prescription in clinical practice. Based on current evidences and our clinical experiences, we debate several emerging issues including drug adherence, dose titration, adverse effect and prognostic benefit, hoping to catch the attention of digestive specialists and healthcare providers.

Key words: Liver cirrhosis, Non-selective β-blockers, Portal hypertension

Xing Wang, Bin Wu. Several hotspots and thinking in the use of non-selective β-blockers in Chinese cirrhosis patients[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2020, 10(05): 193-195.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2020.05.001

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2020/V10/I05/193

References 20

1	GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet Gastroenterol Hepatol, 2020, 5(3): 245-266.
2	Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases [J]. Hepatology, 2017, 65(1): 310-335.
3	Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis [J]. J Hepatol, 2017, 66(4): 849-859.
4	Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients [J]. Gut, 2015, 64(11): 1680-1704.
5	de Franchis R, Baveno Ⅵ Faculty. Expanding consensus in portal hypertension: report of the Baveno Ⅵ Consensus Workshop: Stratifying risk and individualizing care for portal hypertension [J]. J Hepatol, 2015, 63(3): 743-752.
6	中华医学会肝病学分会，中华医学会消化病学分会，中华医学会消化内镜学分会,等.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].中华内科杂志, 2016, 55(1): 57-72.
7	Shukla R, Kramer J, Cao Y, et al. Risk and predictors of variceal bleeding in cirrhosis patients receiving primary prophylaxis with non-selective beta-blockers [J]. Am J Gastroenterol, 2016, 111(12): 1778-1787.
8	Lv Y, Zuo L, Zhu X, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study [J]. Gut, 2019, 68(7): 1297-1310.
9	Reiberger T, Ulbrich G, Ferlitsch A, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol [J]. Gut, 2013, 62(11): 1634-1641.
10	Zhang F, Xu H, Chen M, et al. Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices [J]. Eur J Gastroenterol Hepatol, 2019, 31(3): 368-374.
11	李晶，孙东杰，王广川,等.卡维地洛与普萘洛尔降低肝硬化门静脉高压患者肝静脉压力梯度效果的对比分析[J].临床肝胆病杂志, 2016, 32(1): 114-118.
12	Zacharias AP, Jeyaraj R, Hobolth L, et al. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices [J]. Cochrane Database Syst Rev, 2018, 10(10): CD011510.
13	Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial [J]. Lancet, 2019, 393(10181): 1597-1608.
14	Pfisterer N, Dexheimer C, Fuchs EM, et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding [J]. Aliment Pharmacol Ther, 2018, 47(7): 966-979.
15	Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: Evidence-based indications and limitations [J]. JHEP Rep, 2020, 2(1): 100063.
16	中国门静脉高压诊断与监测研究组(CHESS)，中华医学会消化病学分会微创介入协作组，中国医师协会介入医师分会急诊介入专业委员会,等.中国肝静脉压力梯度临床应用专家共识(2018版) [J].中华消化杂志, 2018, 38(11): 728-738.
17	Kim TW, Kim HJ, Chon CU, et al. Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis? [J]. Clin Mol Hepatol, 2012, 18(2): 203-212.
18	Park JH, Jun DW, Choi J, et al. Low-dose propranolol as secondary prophylaxis for varix bleeding decreases mortality and rebleeding rate in patients with tense ascites [J]. J Clin Med, 2019, 8(5): 573.
19	Kockerling D, Nathwani R, Forlano R, et al. Current and future pharmacological therapies for managing cirrhosis and its complications [J]. World J Gastroenterol, 2019, 25(8): 888-908.
20	Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care [J]. J Hepatol, 2020, 73(2): 441-445.

[1]	Di Zhang, Zhenmao Li, Lixue Yin, Chao Zhou, Lei Lei, Shiyu Yi, Yizhen Li, Hailing Shao, Hongmei Zhang. Prediction of efficacy of endoscopic therapy of liver cirrhosis with esophagogastric varices by contrast transthoracic echocardiography [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(06): 514-520.
[2]	Jianmei Li, Jingjuan Deng, Qian Yang. Safety and follow-up evaluation of the combined treatment of hepatocellular carcinoma with hepatic cirrhosis and portal hypertension [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 41-44.
[3]	Fangyuan Wu, Xia Sun, Changfeng Lin, Zhensheng Zhang. Risk factors of HBV-associated cirrhosis complicated with acute upper gastrointestinal bleeding [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 45-47.
[4]	Xian Mo, Chuang Yang. Meta-analysis of risk factors for portal vein thrombosis in patients with cirrhosis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 678-683.
[5]	Zhida Geng, Xingxin Yu, Yu Liu, Yingjian Liang. Research progress on portal vein system thrombosis and its mechanism after splenectomy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(01): 110-113.
[6]	Xuexue Lei, Ying Yu, Hongyan Li. Clinical research of multimodal prehabilitation optimization program in patients with hepatitis B virus-related liver cirrhosis awaiting liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(03): 158-163.
[7]	Xiaobei Zhang, Dong Cao, Baoshun Yang, Yongjiang Yu. Progress in the clinical management of cirrhotic ascites combined with inguinal hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(02): 121-124.
[8]	Yuyang Xu, Yunfu Lyu, Baochun Wang. Progress of surgical treatments for splenomegaly in patients with hepatitis B cirrhotic portal hypertension [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 469-473.
[9]	Yong Li, Chuan Lan, Bin Wu, Guangnian Zhang, Jingdong Li. Predictive value of preoperative platelet-albumin score for postoperative prognosis of cirrhotic hepatocellular carcinoma patients [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 412-416.
[10]	Linqing Yang, Song Ren, Fanpu Ji, Jian Zhang, An Jiang, Li Zhang, Peng An, Lin Wang, Zongfang Li. Therapeutic effect of needle-embedding therapy on regulating gastrointestinal function after splenectomy and devascularization for portal hypertension [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 322-326.
[11]	Wei Qin, Dan Wang, Yu Sun, Yuling Huo, Suping Zhu, Yanli Zheng, Rui Xue. Predictive value of serum laminin and typeⅣcollagen on liver cirrhosis with ophageal and gastric varices bleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 447-451.
[12]	Wen Zhang, Mudan Song, Xueting Deng, Yun Zhang. Enhanced nutritional support assisted with octreotide in the treatment of esophageal and gastric variceal bleeding in patients with liver cirrhosis and risk factors for rebleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 456-460.
[13]	Xiangyu Zhu, Jianmei Wang, Hui Zhang, Hongying Ye. Correlation analysis between left ventricular function parameters and liver cirrhosis using non-invasive left ventricular pressure-strain cycle [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 494-498.
[14]	Fengshang Zhu, Ling She, Yongnian Ding, Changqing Yang. Application of the five-step questioning method in clinical teaching of cirrhotic portal hypertension [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(02): 116-118.
[15]	Huiping Wei, Yingming Guo, Guirong Liu, Zongyou Wu, Qiuqing Weng. Application value of superoxide dismutase test in hepatitis B virus related liver disease [J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2023, 11(01): 21-26.

Please choose a citation manager

Content to export